The next board meeting for Travere Therapeutics Inc is on 15 May 2026 for the purpose of Travere Therapeutics Inc Annual General Meeting for 2026See details
Travere Therapeutics Inc has a share price target of US$ 53, revenue growth forecast of 42.6%, and profit growth estimate of 185.7% for FY26, based on top 15 analyst calls.